Roxindole

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRoxindole
Drug Alias Name罗克吲哚roxindolroxindoleroxindolumEMD-49980 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSerotonin 1a (5-HT1a) receptor agonistsDopamine D2 receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorDopamine D2 receptorSerotonin transporter
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksWikipedia